Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study).
about
Treatment of proliferative diabetic retinopathy with anti-VEGF agents.[Pharmacological treatment for retinopathy of prematurity].Anti-VEGF Agents for Ocular Angiogenesis and Vascular PermeabilityVisual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK studySurgical management of diabetic retinopathy.A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy.Effect of intravitreal bevacizumab injection before vitrectomy on proliferative diabetic retinopathy.Surgery for Diabetic Eye Complications.Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.Bevacizumab as an adjunct to vitreoretinal surgery for diabetic retinopathy in East Africa.Surgical management of the late complications of proliferative diabetic retinopathy.Treatment of diabetic retinopathy with anti-VEGF drugs.Current and investigational pharmacotherapeutic approaches for modulating retinal angiogenesis.Bevacizumab prior to vitrectomy for diabetic traction retinal detachment.Perfluorocarbon-perfused 23 gauge three-dimensional vitrectomy for complicated diabetic tractional retinal detachment.Vitrectomy surgery of diabetic retinopathy complications.Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.Pars plana vitrectomy in vitreous hemorrhage with or without Intravitreal Bevacizumab a comparative overview.
P2860
Q33812021-4B4B3B8E-321F-4046-B1EA-B125318A8952Q33997311-4F0FD987-15FF-4B8A-B9CE-057A5FB6B1E1Q34088274-E93AA28F-9B6A-41D3-AE1E-F76695CF5F3CQ34119754-7143086E-76E3-4A26-AEAB-0E5B2C23920AQ35067106-94040B07-F7C7-4AE4-A2AD-758EE5486DEFQ35180490-27945355-CE7A-4E19-B0B1-6ED99A5703D7Q35923669-FFFE612F-D5A9-4021-AC34-473D9482334DQ36128850-C030C234-C478-4413-B239-8C2B3B2DE0B1Q36743033-2810AC5A-B5B6-47ED-8A9F-5BDCFC82424BQ37317228-C0C06F01-C809-4453-9CBB-C829BCB4423CQ37688872-C2093443-19C3-46D0-A927-22D3B226800DQ37806321-E8C2D1CC-0B39-4D25-90A4-D659326E31ACQ38192060-329AFE74-A472-4EBD-9039-59AA8D6C6224Q38543178-442E53F3-67E8-4EC8-A93A-C82D259CFF22Q40393328-C6B88AFD-BD2B-46EF-A980-06693D48CE4FQ47130517-0797523D-2743-412C-912F-F27D08A39E58Q47300238-2BBA5882-573C-433C-BF4D-7A1A4A2DFC96Q55057576-589805B9-A0A8-4272-B4FE-4B9A4A09D82A
P2860
Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study).
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Intraoperative bleeding during ...... al bevacizumab (IBeTra study).
@en
Intraoperative bleeding during ...... ative intravitreal bevacizumab
@nl
type
label
Intraoperative bleeding during ...... al bevacizumab (IBeTra study).
@en
Intraoperative bleeding during ...... ative intravitreal bevacizumab
@nl
prefLabel
Intraoperative bleeding during ...... al bevacizumab (IBeTra study).
@en
Intraoperative bleeding during ...... ative intravitreal bevacizumab
@nl
P2093
P50
P356
P1476
Intraoperative bleeding during ...... eal bevacizumab (IBeTra study)
@en
P2093
D da R Lucena
J C Barbosa
L L de Figueiredo-Pontes
P304
P356
10.1136/BJO.2008.151233
P407
P577
2009-02-10T00:00:00Z